Skip to main content
Study: Antiretroviral drug candidate effective, well-tolerated
3/12/2018

A late-stage study of Merck's pipeline candidate doravirine, an antiretroviral therapy, found the drug to be effective and well-tolerated, according to data presented at the annual Conference on Retroviruses and Opportunistic Infections.

Full Story: